AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32783547 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (MTX, hydroxychloroquine plus vitamin D)
Number of subjects: 40
Study 33940337 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS over the DLPFC
Number of subjects: 20
Study 33940337 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 20
Study 32336267 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical clowning intervention
Number of subjects: 70
Study 32336267 — intervention group
Group type: COMPARATOR
Intervention: Reference group (no medical clowning)
Number of subjects: 70
Study 34551104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5-vectored COVID-19 vaccine (5 × 10^10 viral particles)
Number of subjects: 430
Study 34551104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5-vectored COVID-19 vaccine (single dose)
Number of subjects: 430
Study 34551104 — intervention group
Group type: EXPERIMENTAL
Intervention: Homologous prime-boost vaccination
Number of subjects: 430
Study 34551104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 430
Study 34776151 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Massage (TM)
Number of subjects: 60
Study 34776151 — intervention group
Group type: EXPERIMENTAL
Intervention: Positional Release Therapy (PRT)
Number of subjects: 60
Study 34776151 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study 35964101 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month multimodal physical activity promotion/education intervention
Number of subjects: 200
Study 35964101 — intervention group
Group type: COMPARATOR
Intervention: Control (no further attention)
Number of subjects: 200
Study 33979802 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention with weekly goals
Number of subjects: 30
Study 32801651 — intervention group
Group type: EXPERIMENTAL
Intervention: JPI-289 35 mg
Number of subjects: 64
Study 32801651 — intervention group
Group type: EXPERIMENTAL
Intervention: JPI-289 75 mg
Number of subjects: 64
Study 32801651 — intervention group
Group type: EXPERIMENTAL
Intervention: JPI-289 150 mg
Number of subjects: 64
Study 32801651 — intervention group
Group type: EXPERIMENTAL
Intervention: JPI-289 300 mg
Number of subjects: 64
Study 32801651 — intervention group
Group type: EXPERIMENTAL
Intervention: JPI-289 450 mg
Number of subjects: 64
Study 32801651 — intervention group
Group type: EXPERIMENTAL
Intervention: JPI-289 600 mg
Number of subjects: 64
Study 32801651 — intervention group
Group type: EXPERIMENTAL
Intervention: JPI-289
Number of subjects: 64
Study 32801651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 35320359 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant osimertinib
Number of subjects: 0
Study 35320359 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 35997135 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing slippers
Number of subjects: 0
Study 35997135 — intervention group
Group type: COMPARATOR
Intervention: No slippers (control)
Number of subjects: 0
Study 34192850 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedicled abdominal flap
Number of subjects: 98
Study 34192850 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedicled internal hand flap
Number of subjects: 98
Study 34192850 — intervention group
Group type: EXPERIMENTAL
Intervention: Free tissue flap
Number of subjects: 98
Study 32402554 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 463
Study 32402554 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 463
Study 32402554 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 463
Study 32402554 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment (overall)
Number of subjects: 463
Study 32402554 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (between 2 and 5 years)
Number of subjects: 463
Study 32402554 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (baseline VA 20/50 to 20/320)
Number of subjects: 463
Study 32402554 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (baseline VA 20/32 to 20/40)
Number of subjects: 463
Study 32402554 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (CST)
Number of subjects: 463
Study 35277669 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical masks (mask-on)
Number of subjects: 265
Study 35277669 — intervention group
Group type: COMPARATOR
Intervention: No surgical masks (mask-off)
Number of subjects: 265
Study 32615110 — intervention group
Group type: COMPARATOR
Intervention: Weekly paclitaxel (80 mg/m2) with carboplatin AUC5 or AUC6 every 3 weeks (group 2)
Number of subjects: 1566
Study 32615110 — intervention group
Group type: COMPARATOR
Intervention: Weekly paclitaxel (80 mg/m2) with carboplatin AUC2 weekly (group 3)
Number of subjects: 1566
Study 32615110 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-weekly chemotherapy (carboplatin AUC5 or AUC6 and 175 mg/m2 intravenous paclitaxel) (group 1)
Number of subjects: 1566
Study 34417553 — intervention group
Group type: EXPERIMENTAL
Intervention: Take CHARGE (n=85)
Number of subjects: 171
Study 34417553 — intervention group
Group type: COMPARATOR
Intervention: PE Planners (n=86)
Number of subjects: 171
Study 33019896 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of diabetic retinopathy (DR) at baseline
Number of subjects: 2828
Study 33019896 — intervention group
Group type: COMPARATOR
Intervention: No diabetic retinopathy (DR) at baseline
Number of subjects: 2828
Study 34501553 — intervention group
Group type: EXPERIMENTAL
Intervention: AerG (aerobic group)
Number of subjects: 102
Study 34501553 — intervention group
Group type: EXPERIMENTAL
Intervention: IntG (intensity group)
Number of subjects: 102
Study 34501553 — intervention group
Group type: EXPERIMENTAL
Intervention: ComG (combined group)
Number of subjects: 102
Study 34501553 — intervention group
Group type: COMPARATOR
Intervention: CG (control group)
Number of subjects: 102
Study 33888772 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin/metformin 2.5/850 mg twice daily (LM group)
Number of subjects: 31
Study 33888772 — intervention group
Group type: COMPARATOR
Intervention: metformin 850 mg twice daily (M group)
Number of subjects: 31
Study 33308425 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabotegravir plus rilpivirine long‐acting every 8 weeks (cabotegravir 600 mg plus rilpivirine 900 mg)
Number of subjects: 1045
Study 33308425 — intervention group
Group type: COMPARATOR
Intervention: Cabotegravir plus rilpivirine long‐acting every 4 weeks (cabotegravir 400 mg plus rilpivirine 600 mg)
Number of subjects: 1045
Study 32312288 — intervention group
Group type: EXPERIMENTAL
Intervention: Incident delirium
Number of subjects: 1495
Study 32312288 — intervention group
Group type: EXPERIMENTAL
Intervention: Days spent with delirium
Number of subjects: 1495
Study 32312288 — intervention group
Group type: EXPERIMENTAL
Intervention: Days spent with coma
Number of subjects: 1495
Study 32312288 — intervention group
Group type: EXPERIMENTAL
Intervention: Days spent with delirium or coma
Number of subjects: 1495
Study 35773357 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg
Number of subjects: 308
Study 35773357 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg
Number of subjects: 308
Study 35773357 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Tadalafil 5 mg and Silodosin 8 mg
Number of subjects: 308
Study 34177933 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy combined with pembrolizumab
Number of subjects: 1
Study 34177933 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy and immunotherapy
Number of subjects: 1
Study 35685986 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg intravenously before surgery
Number of subjects: 64
Study 35685986 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 64
Study 32880094 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored work-related support intervention (3 psychosocial meetings before treatment)
Number of subjects: 88
Study 32880094 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 88
Study 32880094 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored work-related support intervention
Number of subjects: 88
Study 36201701 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Osteotomy Guide (EOG)
Number of subjects: 28
Study 36201701 — intervention group
Group type: COMPARATOR
Intervention: Traditional Osteotomy Guide (TOG)
Number of subjects: 28
Study 33430785 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component, non-pharmacological intervention to prevent and reduce sleep problems
Number of subjects: 24
Study 33430785 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 24
Study 33430785 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component, non-pharmacological intervention
Number of subjects: 24
Study 36244652 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose losartan (150 mg/d)
Number of subjects: 3834
Study 36244652 — intervention group
Group type: COMPARATOR
Intervention: Low-dose losartan (50 mg/d)
Number of subjects: 3834
Study 32479559 — intervention group
Group type: EXPERIMENTAL
Intervention: Struck singing bowl
Number of subjects: 58
Study 32479559 — intervention group
Group type: COMPARATOR
Intervention: Silent singing bowl
Number of subjects: 58
Study 33419660 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Initiation Program
Number of subjects: 189
Study 33419660 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 189
Study 35676679 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-setting lifestyle intervention (school-, family-, and community-based programs)
Number of subjects: 2374
Study 35676679 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2374
Study 35676679 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-setting lifestyle intervention
Number of subjects: 2374
Study 34755519 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg once daily for 25 to 45 days
Number of subjects: 16496
Study 34755519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16496
Study 32164687 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation program supported by information and communication technologies
Number of subjects: 0
Study 34052865 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic cartilage–perichondrium modified over‐underlay myringoplasty (MOUM)
Number of subjects: 99
Study 34052865 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic cartilage–perichondrium transtympanic underlay alone myringoplasty (TUAM)
Number of subjects: 99
Study 33179856 — intervention group
Group type: EXPERIMENTAL
Intervention: pre‐BAV (pre-dilatation)
Number of subjects: 171
Study 33179856 — intervention group
Group type: COMPARATOR
Intervention: no‐BAV (no pre-dilatation)
Number of subjects: 171
Study 35659791 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraviolet-C (UV-C) light treatment with a room decontamination device
Number of subjects: 0
Study 35659791 — intervention group
Group type: COMPARATOR
Intervention: Sodium hypochlorite delivered via an electrostatic sprayer
Number of subjects: 0
Study 33243308 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Network Intervention (SNI)
Number of subjects: 451
Study 33243308 — intervention group
Group type: COMPARATOR
Intervention: Active Control
Number of subjects: 451
Study 33243308 — intervention group
Group type: COMPARATOR
Intervention: Control Condition
Number of subjects: 451
Study 36227593 — intervention group
Group type: EXPERIMENTAL
Intervention: EX (multicomponent exercise program)
Number of subjects: 120
Study 36227593 — intervention group
Group type: COMPARATOR
Intervention: BAT (balance and tone control group)
Number of subjects: 120
Study 33793043 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel PRP (single spin and low-temperature activation)
Number of subjects: 21
Study 33793043 — intervention group
Group type: COMPARATOR
Intervention: Conventional PRP (double spin and calcium activation)
Number of subjects: 21
Study 32453759 — intervention group
Group type: EXPERIMENTAL
Intervention: dezocine (1 mg/kg) with sufentanil (1.3 μg/kg)
Number of subjects: 120
Study 32453759 — intervention group
Group type: COMPARATOR
Intervention: sufentanil (2.3 μg/kg)
Number of subjects: 120
Study 35961250 — intervention group
Group type: EXPERIMENTAL
Intervention: idursulfase‐IT 10 mg once a month plus IV idursulfase (0.5 mg/kg) once a week
Number of subjects: 56
Study 35961250 — intervention group
Group type: COMPARATOR
Intervention: early idursulfase‐IT
Number of subjects: 56
Study 35961250 — intervention group
Group type: EXPERIMENTAL
Intervention: idursulfase‐IT
Number of subjects: 56
Study 35668438 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-led educational intervention (12-minute video education on influenza and its vaccination)
Number of subjects: 350
Study 35987809 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements, protein‐rich, high‐fiber diet, care by a professional nutritionist
Number of subjects: 62
Study 35337843 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid training system (HTS)
Number of subjects: 28
Study 35337843 — intervention group
Group type: COMPARATOR
Intervention: Sensory transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 28
Study 32303765 — intervention group
Group type: EXPERIMENTAL
Intervention: EE + DNG
Number of subjects: 59
Study 32303765 — intervention group
Group type: EXPERIMENTAL
Intervention: EV + DNG
Number of subjects: 59
Study 32303765 — intervention group
Group type: COMPARATOR
Intervention: DNG only
Number of subjects: 59
Study 36075592 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingnan Chen's acupuncture (delivered at Shenshu (BL 23), Pishu (BL 20), Guanyuan (CV 4), Sanyinjiao (SP 6), etc.), once every two days, three times a week for 12 weeks.
Number of subjects: 70
Study 36075592 — intervention group
Group type: COMPARATOR
Intervention: Calcitriol soft capsules (0.25 μg each time, twice a day for 12 weeks).
Number of subjects: 70
Study 33878192 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal CO2 gel
Number of subjects: 20
Study 33878192 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel (ultrasound gel)
Number of subjects: 20
Study 35043534 — intervention group
Group type: EXPERIMENTAL
Intervention: Video with a warm expert
Number of subjects: 68
Study 35043534 — intervention group
Group type: EXPERIMENTAL
Intervention: Video displaying a neutral expert
Number of subjects: 68
Study 35043534 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 68
Study 33397297 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching involving whole-body movements
Number of subjects: 0
Study 33397297 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching involving hand movements (i.e. arms and hands)
Number of subjects: 0
Study 33397297 — intervention group
Group type: COMPARATOR
Intervention: Teaching involving minimal motor movements (i.e. seated on a chair using paper and pencil)
Number of subjects: 0
Study 36038580 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco heating products (THPs)
Number of subjects: 0
Study 36038580 — intervention group
Group type: COMPARATOR
Intervention: Conventional cigarettes
Number of subjects: 0
Study 36038580 — intervention group
Group type: COMPARATOR
Intervention: Nicotine replacement therapy (NRT)
Number of subjects: 0
Study 33730885 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative chronic care model (CCM) implementation support for 1 year
Number of subjects: 9
Study 33730885 — intervention group
Group type: COMPARATOR
Intervention: Post-implementation support period
Number of subjects: 9
Study 36202236 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Message
Number of subjects: 1235
Study 36202236 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID‐19 Vaccine Message
Number of subjects: 1235
Study 36202236 — intervention group
Group type: COMPARATOR
Intervention: No Message (control)
Number of subjects: 1235
Study 33127204 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-angle group (N group)
Number of subjects: 43
Study 33127204 — intervention group
Group type: EXPERIMENTAL
Intervention: High-angle group (H group)
Number of subjects: 43
Study 33127204 — intervention group
Group type: COMPARATOR
Intervention: Both groups (N and H)
Number of subjects: 43
Study 32782181 — intervention group
Group type: EXPERIMENTAL
Intervention: Option Grid
Number of subjects: 311
Study 32782181 — intervention group
Group type: EXPERIMENTAL
Intervention: Picture Option Grid
Number of subjects: 311
Study 32782181 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 311
Study 34962157 — intervention group
Group type: EXPERIMENTAL
Intervention: Me & My Wishes videos shared with family
Number of subjects: 50
Study 34962157 — intervention group
Group type: EXPERIMENTAL
Intervention: Me & My Wishes videos shared with staff
Number of subjects: 50
Study 33385534 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber dam isolation
Number of subjects: 38
Study 33385534 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of marginal adaptation of restoration
Number of subjects: 38
Study 33385534 — intervention group
Group type: COMPARATOR
Intervention: Cotton roll isolation
Number of subjects: 38
Study 34479797 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D supplementation (400-1600 IU/d)
Number of subjects: 63
Study 35551318 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral tablets
Number of subjects: 127
Study 35551318 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly vaginal rings
Number of subjects: 127
Study 35551318 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly dual injections
Number of subjects: 127
Study 35551318 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo products
Number of subjects: 127
Study 32203571 — intervention group
Group type: EXPERIMENTAL
Intervention: SDT-based psychological intervention + RA-tailored exercise program (n = 59)
Number of subjects: 115
Study 32203571 — intervention group
Group type: COMPARATOR
Intervention: RA-tailored exercise program only (n = 56)
Number of subjects: 115
Study 32203571 — intervention group
Group type: EXPERIMENTAL
Intervention: SDT-based psychological intervention
Number of subjects: 115
Study 32467108 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic best practice alert (BPA) for telemetry; triggered 1042 alerts during the study.
Number of subjects: 558
Study 32467108 — intervention group
Group type: COMPARATOR
Intervention: Control group (no BPA alerts).
Number of subjects: 558
Study 34456030 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 266
Study 34456030 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 266
Study 34456030 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (Phase II)
Number of subjects: 266
Study 34456030 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine (Phase III)
Number of subjects: 266
Study 33201577 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 g/kg)
Number of subjects: 95
Study 33201577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 35581642 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents' feeding practices and physical activity facilitation
Number of subjects: 70
Study 35581642 — intervention group
Group type: EXPERIMENTAL
Intervention: Household resilience factors (secure housing and employment)
Number of subjects: 70
Study 35581642 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents' emotional and social wellbeing
Number of subjects: 70
Study 33252964 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restructuring intervention
Number of subjects: 209
Study 33252964 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 209
Study 33252964 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 209
Study 33252964 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 209
Study 32253065 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular analgesia + Saphenous Nerve Block (SNB)
Number of subjects: 70
Study 32253065 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular analgesia + Placebo
Number of subjects: 70
Study 35510562 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (vaccine)
Number of subjects: 0
Study 34153931 — intervention group
Group type: EXPERIMENTAL
Intervention: CA prediction nomogram
Number of subjects: 685
Study 35742279 — intervention group
Group type: EXPERIMENTAL
Intervention: Online group (n = 19) - 40‐min trunk stabilization exercise sessions twice a week for six weeks via ZOOM
Number of subjects: 37
Study 35742279 — intervention group
Group type: COMPARATOR
Intervention: Offline group (n = 18) - same program in person
Number of subjects: 37
Study 35742279 — intervention group
Group type: COMPARATOR
Intervention: Comparison of left rectus abdominis thickness and Psychological/Baby and Relational/Spouse‐Partner subscale in maternal quality of life index
Number of subjects: 37
Study 32147709 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month group-based exercise and behavior maintenance program
Number of subjects: 777
Study 32147709 — intervention group
Group type: COMPARATOR
Intervention: Minimal Healthy Aging control intervention
Number of subjects: 777
Study 35290742 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training (VRT) program, 8 weeks, three 30-minute sessions per week using Xbox Kinect headset
Number of subjects: 25
Study 35290742 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training (VRT) program
Number of subjects: 25
Study 34110614 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 1-mg OM slow-release minitablets
Number of subjects: 20
Study 34110614 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 1-mg OM fast-release minitablets
Number of subjects: 20
Study 34110614 — intervention group
Group type: COMPARATOR
Intervention: 25-mg OM matrix MR tablet
Number of subjects: 20
Study 36183099 — intervention group
Group type: EXPERIMENTAL
Intervention: EIT-guided individualized PEEP
Number of subjects: 540
Study 36183099 — intervention group
Group type: COMPARATOR
Intervention: Single PEEP (PEEP = 6 cmH2O)
Number of subjects: 540
Study 34237987 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral S1 nerve root transfer
Number of subjects: 40